Credit: Unsplash/CC0 Public Domain
Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced the publication of positive 12-month results from the CLARITY clinical trial in Laryngoscope Investigative Otolaryngology.
This study demonstrates that treatment with Neurent Medical’s radiofrequency (RF) ablation device, the NEUROMARK system, is safe and resulted in durable, significant improvement in rhinitis symptoms and quality of life through 12-month follow-up. Dr. Reh added, “The CLARITY study results provide compelling evidence of sustained symptom relief for patients.”
Key findings:
Symptom reduction: All 5 Visual Analog Scale Nasal Symptom Score (VAS NSS) items demonstrated significant improvement (p
Information contained on this page is provided by an independent third-party content provider. This website makes no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact editor @americanfork.business
